Identifying patients at risk for augmented renal clearance in the ICU : limitations and challenges by Carlier, Mieke & De Waele, Jan
Th is commentary discusses the ﬁ ndings of Udy and 
colleagues about the augmented renal clearance in septic 
and traumatized patients [1]. Antibiotic therapy is a key 
element of the treatment of patients with severe sepsis 
and septic shock, and success of antibiotic therapy is 
determined by multiple factors. Susceptibility of the 
microorganism to the antibiotic is crucial, but reaching 
an adequate concentration of the drug is equally relevant.
In recent years several studies found that plasma con-
cen trations of antibiotics  - with beta-lactam antibiotics 
investigated most intensely  - are highly variable in 
critically ill patients, with a considerable number of 
patients not reaching adequate concentrations. Several 
factors, such as increased volume of distribution, 
hypoalbuminemia and increased elimination from the 
circulation, have been found to be involved in this 
phenomenon. As most of these antibiotics are primarily 
cleared via the kidneys, renal elimination has been 
studied most extensively, and the state of increased 
elimination of drugs via the kidney has been coined 
‘augmented renal clearance’ (ARC), which is deﬁ ned as a 
creatinine clearance of 130 ml/minute/1.73 m2 or higher 
[2]. Th e incidence of ARC has mainly been studied in 
smaller studies, and depending on the cutoﬀ  used for its 
deﬁ nition and on the studied population, the incidence 
varied from 30% to 85% [3-5].
In their article, Udy and colleagues conﬁ rm the high 
incidence of ARC in a trauma and sepsis population, and 
found that age, trauma as admission diagnosis and a 
Sequential Organ Failure Assessment (SOFA) score of 4 
or less were independently associated with ARC. Although 
they provided us with new insights in the characteristics 
of patients at risk of ARC, they could not translate their 
results into easy to use clinical guidance.
Identifying patients who present with ARC is obviously 
a desirable goal, in order to appropriately treat patients 
with severe infections. However, evaluation of kidney 
function in the ICU is notoriously diﬃ  cult, and conven-
tional biomarkers such as serum creatinine or estimates 
of glomerular ﬁ ltration rate, such as Cockcroft-Gault or 
Modiﬁ cation of Diet in Renal Disease (MDRD) formulas, 
are not reliable, which is also the case in patients with 
ARC [6]. At present, creatinine clearance can most 
conveniently be measured using 8 or 24  h calculated 
creatinine clearance. When these data are not available, 
the results of the current study can serve as a guide to 
screen for ARC.
In the study by Udy and colleagues, cardiac index 
correlated with creatinine clearance - albeit poorly - and 
was not retained in the multivariate analysis. Although 
the methodology for cardiac index measurement used 
could also have inﬂ uenced this ﬁ nding, it may also 
demonstrate that renal clearance is determined by 
multiple factors and the search for surrogate markers 
may be elusive.
Irrespective of the ﬁ ndings reported, several questions 
remain unanswered. Th e incidence of ARC in more 
diverse and other ICU populations has been incompletely 
explored. Also, the dynamics of ARC during ICU stay 
have not been studied. Better methods for the early 
recog nition of patients with ARC are necessary - potentially 
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novel biomarkers such as neutrophil gelatinase-asso-
ciated lipocalin (nGAL; currently mainly investigated in 
the setting of acute kidney failure) are worth exploring. 
Finally, diagnostic accuracy of diﬀ erent methods to 
diagnose ARC, including measured creatinine clearance, 
needs urgently to be determined.
Other than focusing on factors associated with the 
determinants of changed pharmacokinetics of antibiotics, 
performing actual therapeutic drug monitoring (TDM) 
may be an alternative approach. Th is is currently standard 
for drugs that have a narrow therapeutic index such as 
aminoglycosides or glycopeptides, but for other - safer - 
drugs, TDM may oﬀ er a solution to monitor eﬃ  cacy 
rather than toxicity. However, TDM of beta-lactams is 
rarely used in routine practice because the potential 
beneﬁ ts of TDM have not yet been established, and 
because of long turn-around time and high costs.
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